Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis

<table>Forest plot of pooled data on FVC prior (favours control arm) and during treatment with MMF or MS (favours MMF or MS arm). Abbreviations: CI: confidence interval, DL<sub>CO</sub>: diffusing capacity for carbon monoxide, MMF: mycophenolate mofetil, MS: mycophenolate sodium, and SD: standard deviation.</table>

Pulmonary Medicine

fig1

Figure 1

Figure 1: Effect and Safety of Mycophenolate Mofetil or Sodium in Systemic Sclerosis-Associated Interstitial Lung Disease: A Meta-Analysis 